Search results
Why Investors Should Care About Novartis' Latest Label Expansion -- It Could Mean Billions
Motley Fool· 11 months agoEarlier this month, Novartis' (NYSE: NVS) smash-hit immunology medicine Cosentyx became the first...
Novartis' Cosentyx Shows To Ease Symptoms In Painful Skin Condition
Benzinga via Yahoo Finance· 2 years agoNovartis AG (NYSE: NVS) announced the results from two Phase 3 studies (SUNSHINE and SUNRISE) of...
Are your prescription drugs affordable? Colorado board wants feedback on these 2
KDVR Denver via Yahoo News· 1 month agoDENVER (KDVR) — A Colorado board continues reviewing the cost of prescription drugs, and public...
Novartis (NVS) Q2 Earnings Beat, Revenues Miss Estimates
Zacks via Yahoo Finance· 2 years agoNovartis AG NVS reported mixed second-quarter 2022 results. The Sandoz business continues to recover...
Novartis (NVS) Q1 Earnings, Sales Beat, Guidance Raised
Zacks via Yahoo Finance· 1 month agoSwiss pharma giant Novartis AG NVS reported better-than-expected results for the first quarter of...
20 prescription drugs on Colorado’s affordability radar
KDVR Denver via Yahoo News· 2 months agoDENVER (KDVR) — The Colorado board created to review prescription drug prices is headed to court...
2 Green Flags and 1 Red Flag for Novartis Stock
Motley Fool· 7 months agoShare prices of Swiss pharmaceutical company Novartis (NYSE: NVS) have climbed more than 10% so far this year. The company focuses on cardiovascular,...
These 5 Price-to-Sales Stocks Can Be Rewarding Investments
Zacks via Yahoo Finance· 1 year agoThe price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an...
What's in Store for Novartis (NVS) This Earnings Season?
Zacks via Yahoo Finance· 2 years agoInvestors will focus on the regular top and bottom-line numbers along with updates on the Sandoz...
Novartis (NVS) Q4 Earnings Miss on Higher Costs, Sales Lag
Zacks via Yahoo Finance· 4 months agoSwiss pharma giant Novartis AG NVS reported lower-than-expected results in the fourth quarter of...